| Drexell H Boggs, MD | |
|
1700 6th Ave S, Rm: 2253, Birmingham, AL 35233-1802 | |
| (205) 975-9399 | |
| (205) 975-5184 |
| Full Name | Drexell H Boggs |
|---|---|
| Gender | Male |
| Speciality | Radiation Oncology |
| Experience | 14 Years |
| Location | 1700 6th Ave S, Birmingham, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003131558 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0001X | Radiology - Radiation Oncology | MD.33808 (Alabama) | Primary |
| 2085R0001X | Radiology - Radiation Oncology | 33808 (Alabama) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Alabama Hospital | Birmingham, AL | Hospital |
| Russell Medical Center | Alexander city, AL | Hospital |
| Northeast Alabama Regional Medical Center | Anniston, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Proton International Alabama, Llc | 8325472814 | 15 |
| Russell Oncology Jv Physicians Services, Llc | 2769737287 | 3 |
| The Russell Hospital Corporation | 6406754431 | 52 |
| University Of Alabama Health Services Foundation, Pc | 1951213107 | 2344 |
News Archive
Shire plc, the global specialty biopharmaceutical company, today presented positive data from a Phase III clinical trial (TKT-034) designed to evaluate the safety of switching to VPRIV (velaglucerase alfa for injection), from imiglucerase, as well as an interim analysis of safety data from an ongoing multicenter open-label treatment protocol (HGT-GCB-058) implemented to provide VPRIV to patients affected by the continuing shortage of imiglucerase.
FASgen Inc. announced it has successfully expanded the potential use for its serum FAS (fatty acid synthase) ELISA diagnostic research test, FAS-Detect ELISA for the identification of Non-Alcoholic Steatophepititis (NASH).
A study that compared total U.S. diabetes diagnoses over a 26-year period found that while the prevalence nearly doubled, from 5.5 to 10.8 percent, the proportion of missed cases of diabetes dropped significantly during the same period, from 16.3 to 10.9 percent.
The U.N. Food and Agriculture Organization (FAO) "on Thursday warned climate change will restrict the availability of water for farming in decades to come, including in the Mediterranean region, and urged governments to take action," Agence France-Presse reports.
Particle beam radiation therapy, a technology used to treat several types of cancer, is considered by some clinicians to be better than traditional radiation, but there is limited evidence about its safety compared with other types of radiation therapy, according to a new comparative effectiveness report funded by HHS' Agency for Healthcare Research and Quality.
› Verified 7 days ago
| Entity Name | University Of Alabama Health Services Foundation, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093768723 PECOS PAC ID: 1951213107 Enrollment ID: O20031105000261 |
News Archive
Shire plc, the global specialty biopharmaceutical company, today presented positive data from a Phase III clinical trial (TKT-034) designed to evaluate the safety of switching to VPRIV (velaglucerase alfa for injection), from imiglucerase, as well as an interim analysis of safety data from an ongoing multicenter open-label treatment protocol (HGT-GCB-058) implemented to provide VPRIV to patients affected by the continuing shortage of imiglucerase.
FASgen Inc. announced it has successfully expanded the potential use for its serum FAS (fatty acid synthase) ELISA diagnostic research test, FAS-Detect ELISA for the identification of Non-Alcoholic Steatophepititis (NASH).
A study that compared total U.S. diabetes diagnoses over a 26-year period found that while the prevalence nearly doubled, from 5.5 to 10.8 percent, the proportion of missed cases of diabetes dropped significantly during the same period, from 16.3 to 10.9 percent.
The U.N. Food and Agriculture Organization (FAO) "on Thursday warned climate change will restrict the availability of water for farming in decades to come, including in the Mediterranean region, and urged governments to take action," Agence France-Presse reports.
Particle beam radiation therapy, a technology used to treat several types of cancer, is considered by some clinicians to be better than traditional radiation, but there is limited evidence about its safety compared with other types of radiation therapy, according to a new comparative effectiveness report funded by HHS' Agency for Healthcare Research and Quality.
› Verified 7 days ago
| Entity Name | The Russell Hospital Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811913460 PECOS PAC ID: 6406754431 Enrollment ID: O20040109000579 |
News Archive
Shire plc, the global specialty biopharmaceutical company, today presented positive data from a Phase III clinical trial (TKT-034) designed to evaluate the safety of switching to VPRIV (velaglucerase alfa for injection), from imiglucerase, as well as an interim analysis of safety data from an ongoing multicenter open-label treatment protocol (HGT-GCB-058) implemented to provide VPRIV to patients affected by the continuing shortage of imiglucerase.
FASgen Inc. announced it has successfully expanded the potential use for its serum FAS (fatty acid synthase) ELISA diagnostic research test, FAS-Detect ELISA for the identification of Non-Alcoholic Steatophepititis (NASH).
A study that compared total U.S. diabetes diagnoses over a 26-year period found that while the prevalence nearly doubled, from 5.5 to 10.8 percent, the proportion of missed cases of diabetes dropped significantly during the same period, from 16.3 to 10.9 percent.
The U.N. Food and Agriculture Organization (FAO) "on Thursday warned climate change will restrict the availability of water for farming in decades to come, including in the Mediterranean region, and urged governments to take action," Agence France-Presse reports.
Particle beam radiation therapy, a technology used to treat several types of cancer, is considered by some clinicians to be better than traditional radiation, but there is limited evidence about its safety compared with other types of radiation therapy, according to a new comparative effectiveness report funded by HHS' Agency for Healthcare Research and Quality.
› Verified 7 days ago
| Entity Name | Russell Oncology Jv Physicians Services, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831604156 PECOS PAC ID: 2769737287 Enrollment ID: O20180623000182 |
News Archive
Shire plc, the global specialty biopharmaceutical company, today presented positive data from a Phase III clinical trial (TKT-034) designed to evaluate the safety of switching to VPRIV (velaglucerase alfa for injection), from imiglucerase, as well as an interim analysis of safety data from an ongoing multicenter open-label treatment protocol (HGT-GCB-058) implemented to provide VPRIV to patients affected by the continuing shortage of imiglucerase.
FASgen Inc. announced it has successfully expanded the potential use for its serum FAS (fatty acid synthase) ELISA diagnostic research test, FAS-Detect ELISA for the identification of Non-Alcoholic Steatophepititis (NASH).
A study that compared total U.S. diabetes diagnoses over a 26-year period found that while the prevalence nearly doubled, from 5.5 to 10.8 percent, the proportion of missed cases of diabetes dropped significantly during the same period, from 16.3 to 10.9 percent.
The U.N. Food and Agriculture Organization (FAO) "on Thursday warned climate change will restrict the availability of water for farming in decades to come, including in the Mediterranean region, and urged governments to take action," Agence France-Presse reports.
Particle beam radiation therapy, a technology used to treat several types of cancer, is considered by some clinicians to be better than traditional radiation, but there is limited evidence about its safety compared with other types of radiation therapy, according to a new comparative effectiveness report funded by HHS' Agency for Healthcare Research and Quality.
› Verified 7 days ago
| Entity Name | Proton International Alabama, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649736752 PECOS PAC ID: 8325472814 Enrollment ID: O20191216000981 |
News Archive
Shire plc, the global specialty biopharmaceutical company, today presented positive data from a Phase III clinical trial (TKT-034) designed to evaluate the safety of switching to VPRIV (velaglucerase alfa for injection), from imiglucerase, as well as an interim analysis of safety data from an ongoing multicenter open-label treatment protocol (HGT-GCB-058) implemented to provide VPRIV to patients affected by the continuing shortage of imiglucerase.
FASgen Inc. announced it has successfully expanded the potential use for its serum FAS (fatty acid synthase) ELISA diagnostic research test, FAS-Detect ELISA for the identification of Non-Alcoholic Steatophepititis (NASH).
A study that compared total U.S. diabetes diagnoses over a 26-year period found that while the prevalence nearly doubled, from 5.5 to 10.8 percent, the proportion of missed cases of diabetes dropped significantly during the same period, from 16.3 to 10.9 percent.
The U.N. Food and Agriculture Organization (FAO) "on Thursday warned climate change will restrict the availability of water for farming in decades to come, including in the Mediterranean region, and urged governments to take action," Agence France-Presse reports.
Particle beam radiation therapy, a technology used to treat several types of cancer, is considered by some clinicians to be better than traditional radiation, but there is limited evidence about its safety compared with other types of radiation therapy, according to a new comparative effectiveness report funded by HHS' Agency for Healthcare Research and Quality.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Drexell H Boggs, MD 1700 6th Ave S, Rm: 2253, Birmingham, AL 35233-1802 Ph: (205) 975-9399 | Drexell H Boggs, MD 1700 6th Ave S, Rm: 2253, Birmingham, AL 35233-1802 Ph: (205) 975-9399 |
News Archive
Shire plc, the global specialty biopharmaceutical company, today presented positive data from a Phase III clinical trial (TKT-034) designed to evaluate the safety of switching to VPRIV (velaglucerase alfa for injection), from imiglucerase, as well as an interim analysis of safety data from an ongoing multicenter open-label treatment protocol (HGT-GCB-058) implemented to provide VPRIV to patients affected by the continuing shortage of imiglucerase.
FASgen Inc. announced it has successfully expanded the potential use for its serum FAS (fatty acid synthase) ELISA diagnostic research test, FAS-Detect ELISA for the identification of Non-Alcoholic Steatophepititis (NASH).
A study that compared total U.S. diabetes diagnoses over a 26-year period found that while the prevalence nearly doubled, from 5.5 to 10.8 percent, the proportion of missed cases of diabetes dropped significantly during the same period, from 16.3 to 10.9 percent.
The U.N. Food and Agriculture Organization (FAO) "on Thursday warned climate change will restrict the availability of water for farming in decades to come, including in the Mediterranean region, and urged governments to take action," Agence France-Presse reports.
Particle beam radiation therapy, a technology used to treat several types of cancer, is considered by some clinicians to be better than traditional radiation, but there is limited evidence about its safety compared with other types of radiation therapy, according to a new comparative effectiveness report funded by HHS' Agency for Healthcare Research and Quality.
› Verified 7 days ago
Dr. Garrett Colby, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 619 19th St S, Jt N342, Birmingham, AL 35249 Phone: 205-934-3108 Fax: 205-975-4413 | |
James Walker, Radiology Medicare: Accepting Medicare Assignments Practice Location: 1717 6th Ave S, Birmingham, AL 35233 Phone: 800-822-8816 | |
Joseph Smith, Radiology Medicare: Accepting Medicare Assignments Practice Location: 1717 6th Ave S, Birmingham, AL 35233 Phone: 800-822-8816 | |
Michelle M Mcnamara, MD Radiology Medicare: Medicare Enrolled Practice Location: 619 19th Street South, Birmingham, AL 35233 Phone: 205-934-4011 | |
Sharda Mehar Bajaj, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1526 5th Ave S, Birmingham, AL 35233 Phone: 205-279-2860 | |
Gina Elizabeth Rebesco, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 625 19th St S, Birmingham, AL 35233 Phone: 205-975-0222 |